News from all angles
(MedPage Today) -- Antithrombotic monotherapy was similar to dual antiplatelet therapy (DAPT) for 6-month outcomes after left atrial appendage (LAA) closure, the SIMPLAAFY trial showed. The incidence…
Redirecting to MedPage Today in 3 seconds...
Share this story with your network